Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

EUS-GE vs ES for Palliation of Gastric Outlet Obstruction

NCT: NCT03259763 · COMPLETED

NCT IDNCT03259763
StatusCOMPLETED
Start Date2020-10-26
Completion2026-01-15
SponsorJohns Hopkins University (OTHER)
First posted
Last updated

Brief Summary

Gastric outlet obstruction (GOO) is a common complication of luminal malignancies which is associated with substantial morbidity. Palliation of GOO has traditionally been through the surgical bypass of the obstructed lumen by creating an opening between the stomach and small intestine. However, In recent years, a less invasive approach, i.e. endoscopic stenting, has gained wide acceptance to treat unresectable malignant gastric outlet obstruction. In this study, the investigators are going to compare the safety and efficacy of the two different endoscopic techniques including Endoscopic ultrasonography-guided gastroenterostomy (EUS-GE) and enteral stenting (ES).

Frequently Asked Questions

What is EUS-GE vs ES for Palliation of Gastric Outlet Obstruction?

EUS-GE vs ES for Palliation of Gastric Outlet Obstruction is a clinical trial registered under NCT03259763. Current status: COMPLETED.

What is the status of NCT03259763?

The current status of NCT03259763 (EUS-GE vs ES for Palliation of Gastric Outlet Obstruction) is: COMPLETED.

When did EUS-GE vs ES for Palliation of Gastric Outlet Obstruction start?

EUS-GE vs ES for Palliation of Gastric Outlet Obstruction started on 2020-10-26.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.